Riskpilot← Back to searchSign inGet full accessTeketopen AB
ABDissolvedOrg 5568118722Medical specialists activities · NACE 8622Est. 20100 employees
Revenue 2024
SEK 7,7M
+49% vs 2023
EBITDA margin
-0.1%
-101% vs 2023
Equity ratio
42.3%
Financial strength
Net profit 2024
SEK 14K
-98% vs 2023
| Revenue | SEK 7,7M | +49% |
| EBITDA | SEK -4K | -101% |
| Net profit | SEK 14K | -98% |
| Total assets | SEK 1,6M | -3% |
| Equity | SEK 675K | +2% |
| Employees | 0 | — |
Legal name
Teketopen AB
Org number
5568118722
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
17 juni 2010
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva hälso- och sjukvård i form av: utredning och diagnosticering av barn och unga vuxna där misstanke om neuropsykiatriskt funktionshinder föreligger samt i viss omfattning medverka i utformande av åtgärdsplaner och ge avgränsade behandlingsinsatser av medicinsk eller KBT-karaktär. Även ge konsultationer och föreläsningar.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 5 460 | 14 606 | 5 874 | 5 149 | 7 689 |
| Staff expenses | — | — | — | −1 080 | −1 427 |
| EBITDA | 249 | 2 034 | 1 072 | 742 | −4 |
| Depreciation & amort. | −7 | −7 | −7 | −2 | — |
| EBIT | 242 | 2 027 | 1 065 | 740 | −4 |
| Net financials | — | −1 | −1 | −5 | −2 |
| Profit before tax | 176 | 1 513 | 1 091 | 765 | 28 |
| Tax | −42 | −329 | −233 | −168 | −14 |
| Net profit | 134 | 1 184 | 858 | 598 | 14 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 225 | 6 761 | 3 472 | 1 639 | 1 596 |
| Equity | 624 | 1 808 | 2 203 | 661 | 675 |
| Long-term debt | 0 | 0 | 0 | — | — |
| Short-term debt | 446 | 4 286 | 628 | 367 | 344 |
| Total debt | 446 | 4 286 | 628 | 367 | 344 |
EBITDA margin
-0.1%
This company
15.8%
Market median
-101% vs market
20202024
Equity ratio
42.3%
This company
38.2%
Market median
+11% vs market
20202024
Return on equity
2.1%
This company
18.4%
Market median
-89% vs market
20202024
Net profit margin
0.2%
This company
8.1%
Market median
-98% vs market
20202024
Asset turnover
4.82×
This company
1.12×
Market median
+330% vs market
20202024
Debt / equity
1.36×
This company
0.62×
Market median
-119% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-09-01 – 2020-08-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
JC Chief Auditor | Chief Auditor | 2020 |
LK Chief Executive Officer | Chief Executive Officer | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2021 | |
| Former (3) | ||
| Board of Directors | 2022 – 2023 | |
| Chairman | 2020 – 2021 | |
| Board of Directors | 2022 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Teketopen AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jenny Camilla Erika Norberg | Chief Auditor | 0 companies |
| Lisa Kristina Ek | Chief Executive Officer | 0 companies |
| Helen Beatrice Pontén | Board of Directors | 0 companies |
| Karin Elisabet Sandberg | Chairman | 0 companies |
| Eva Katarina Olsson | Board of Directors | 0 companies |
| Sanna-Maria Wallje Pettersson | Deputy Board Member | 0 companies |